Accelerated Cure Project for Multiple Sclerosis
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Accelerated Cure Project for Multiple Sclerosis sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
Accelerated Cure Project for Multiple Sclerosis: 3 sponsored US clinical trials, 2 recruiting.
Accelerated Cure Project for Multiple Sclerosis sponsors 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting. The most-studied condition in this pipeline is Multiple Sclerosis, with 3 trials.
Upper-quartile sponsor footprint
Accelerated Cure Project for Multiple Sclerosis sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
3 total, page 1 of 1
Therapeutic Areas
What is open in the Accelerated Cure Project for Multiple Sclerosis pipeline
2 recruiting of 3 indexed (67% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Multiple Sclerosis (3 trials), 5 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Accelerated Cure Project for Multiple Sclerosis: open-pipeline peers nationwide
Peers matched on 3 registered trials and 67% open enrollment, not the therapeutic-area sidebar.
Accelerated Cure Project for Multiple Sclerosis sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 trials (± recruiting share)
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors near 67% open enrollment (± trial volume)
- Abbisko Therapeutics Co · 67% recruiting · 6 trials
- ABL Bio · 67% recruiting · 3 trials
- Advanced Reconstructive Surgery Alliance · 67% recruiting · 3 trials
- Alexander B Olawaiye, MD · 67% recruiting · 3 trials
Related
What to do with this Accelerated Cure Project for Multiple Sclerosis page
3 registered trials is a research-attention snapshot, not an endorsement of Accelerated Cure Project for Multiple Sclerosis or any single study.
- 2 of Accelerated Cure Project for Multiple Sclerosis's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Multiple Sclerosis is the condition Accelerated Cure Project for Multiple Sclerosis studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Sclerosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Accelerated Cure Project for Multiple Sclerosis pipeline card: 3 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.